{"nct_id":"NCT03126591","title":"A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2017-07-03","start_date_type":"ACTUAL","primary_completion_date":"2021-05-06","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}